All the news Showing 10 of 938 articlesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Treatment issues People on methadone can succeed on hepatitis C treatment Liz Highleyman / 18 October 2011 Opiate users on methadone maintenance therapy can be successfully treated for chronic hepatitis C and can achieve outcomes similar to those of people not on methadone, according to data presented at the ... Therapies New anti-hepatitis C drug BMS-790052 does well in Phase IIa study Michael Carter / 20 September 2011 Up to 83% of individuals with chronic hepatitis C virus achieved a sustained virological response after receiving the investigational drug BMS-790052 in combination with pegylated interferon and ribavirin, results of a study presented ... Side effects Coffee consumption reduces side-effects in people on hepatitis C treatment Gus Cairns / 14 September 2011 Drinking three or more cups of coffee a day reduced the incidence of self-reported side-effects by more than 80% compared to non-coffee drinkers in people co-infected with hepatitis C and HIV who were taking ... Hepatitis B Co-infection with hepatitis delta increases risk of death for patients with HIV and chronic hepatitis B Michael Carter / 05 September 2011 Infection with hepatitis delta virus is associated with an increased risk of death for HIV-positive patients with chronic hepatitis B infection, European research published in the online edition of AIDS shows. “In ... Testing for hepatitis C Some rapid hepatitis C tests have high false-negative rate in people with HIV Michael Carter / 22 August 2011 Approximately 9% of hepatitis C infections in HIV-positive individuals are missed by some rapid hepatitis C testing assays, US investigators report in the September 15th edition of the Journal of Infectious Diseases. Three ... Hepatitis E Unexplained liver enzyme increases in patients with HIV could be due to hepatitis E virus: screening recommended Michael Carter / 05 August 2011 Infection with hepatitis E virus should be considered as a possible cause of unexplained elevations in liver enzymes in HIV-positive patients, Swiss investigators suggest in Emerging Infectious Diseases. Approximately 3% of their patients with ... Treatment issues Boceprevir response and resistance differs according to HCV genotype 1 subtype Liz Highleyman / 28 July 2011 People with hepatitis C virus (HCV) genotype 1b respond better to boceprevir and are less likely to develop drug resistance than those with genotype 1a, according to study findings reported ... Hepatitis B Lamivudine has limited impact on HBV for hepatitis B / HIV-coinfected in South African trial Keith Alcorn / 05 July 2011 The inclusion of lamivudine (3TC) in antiretroviral therapy had few additional benefits for South African HIV-positive patients co-infected with hepatitis B, South African investigators report in the online edition of AIDS. Hepatitis B virus (HBV) ... Treatment issues With special training, effective and safe hepatitis C therapy can be provided in primary care Michael Carter / 23 June 2011 Specially trained primary care providers can offer effective and safe treatment for hepatitis C infection, US investigators report in the New England Journal of Medicine. Rates of sustained virological response were the ... Treatment issues Coffee drinking improves hepatitis C treatment response rate in mono-infected patients Michael Carter / 22 June 2011 Coffee drinking is associated with improved responses to hepatitis C therapy, US investigators report in Gastroenterology. After adjustment for other factors, drinking three or more cups of coffee per day increased the chances of ... ← Prev1...9091929394Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive